Trials / Completed
CompletedNCT07181538
Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers
Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of "JLP-2302" and "JP-1366" in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Onconic Therapeutics Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate the pharmacokinetics and the safety after administration of "JLP-2302" and "JP-1366" in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JLP-2302 | taking JLP-2302 |
| DRUG | JP-1366 | taking JP-1366 |
Timeline
- Start date
- 2025-02-04
- Primary completion
- 2025-02-20
- Completion
- 2025-03-05
- First posted
- 2025-09-18
- Last updated
- 2025-09-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07181538. Inclusion in this directory is not an endorsement.